Table 4 Presentation, treatment, and outcome of intraoperative high-risk pulmonary embolism case series
Sex, Age, Date | Surgery | CA Rhythm | CPR* (min) | ROSC | Support* | CTA | ST | Outcome |
|---|---|---|---|---|---|---|---|---|
F, 83, 12/11/2014 | HA | Asystole | 12 | No | High | No | Alteplase 50 mg IV | Dead |
M, 47, 30/07/2015 | RN | PEA (15 m) Asystole (7 m) | 20 | No | High | No | No | Dead |
F, 21, 03/10/2015 | Cesarean section | PEA (5 m) ROSC (60 m) PEA (20 m) | 20 | Yes | High | No | No | Dead |
F, 55, 31/05/2017 | TH | 5 EP PEA | 15 | Yes | High | No | Alteplase 50 mg IV | Dead |
F, 89, 17/04/2018 | HA | PEA (7 m) ROSC (20 m) Asystole (15 m) | 15 | Yes | High | No | No | Dead |
M, 73, 15/12/2019 | TURP | Asystole (12 m) | 12 | No | High | No | No | Dead |
F, 68, 12/07/2022 | BARFC | PEA (3 m) | 3 | Yes | Low | Yes | Enoxaparin40mg/12H | Survived NNS |
F, 74, 21/09/2022 | TKR | PEA (3 m) ROSC (25 m) PEA (4 m) | 4 | Yes | High | No | MT | Survived NNS |